Laurent Poirot

This inventor holds 39 USPTO granted patents and 29 published patent applications, plus 9 CIPO patents and 16 EPO patents, primarily in Cellular Immunotherapy. Top assignees: Cellectis, Allogene Therapeutics, Inc., Cellectis S.a.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurent Poirot. Retrieved from https://idiyas.com/inventor/laurent-poirot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 39 (Patent Applications = 29)

% Patents Active = 89.7

CIPO Patents = 9 (Patent Applications = 17)

EPO Patents = 16 (Patent Applications = 48)

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 134(Granted Patents)

Company Filing History:

Allogene Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

CAR-T Cells

Gene Insertion

T-Cell Engineering

Immunotherapy

Allogeneic Transplantation

Chimeric Antigen Receptors

RNA-Guided Cas Nuclease

Tumor Microenvironment

CRS Inhibitors

TCR Alpha Deficient T Cells

Immune Cells Resistance

Hypersensitive T-Cells

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12680076 - METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY (2026-07-14),

2. 12655451 - TAL- effector nuclease (TALEN) -MODIFIED ALLOGENIC CELLS SUITABLE FOR THERAPY (2026-06-16),

3. 12618048 - DUAL CAR-T CELLS (2026-05-05),

4. 12577581 - USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR ALPHA DEFICIENT T CELLS (2026-03-17),

5. 12391933 - Targeted gene insertion for improved immune cells therapy (2025-08-19),

6. 12365733 - Method for improving production of car T cells (2025-07-22),

7. 12252699 - Method for generating t-cells compatible for allogenic transplantation (2025-03-18),

8. 12221478 - Targeted gene integration of CRS inhibitor genes for improved immune cells therapy (2025-02-11),

9. 12209125 - Targeted gene integration of NK inhibitors genes for improved immune cells therapy (2025-01-28),

10. 12144825 - Cellular immunotherapy for repetitive administration (2024-11-19),

11. 11959091 - Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system (2024-04-16),

12. 11903968 - Engineered immune cells resistant to tumor microenvironment (2024-02-20),

13. 11891614 - Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapy (2024-02-06),

14. 11873511 - Targeted gene insertion for improved immune cells therapy (2024-01-16),

15. 11820996 - Method for generating T-cells compatible for allogenic transplantation (2023-11-21),

Title: The Innovative Mind of Laurent Poirot

Introduction: Laurent Poirot, a visionary inventor hailing from Paris, France, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Laurent Poirot holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing his versatility and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, Laurent Poirot has worked with leading tech companies and research institutions, spearheading projects that have revolutionized various industries. His keen eye for detail and passion for innovation have earned him a reputation as a trailblazer in the field.

Collaborations: Throughout his career, Laurent Poirot has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of creativity and excellence. His ability to bring together diverse talents has led to the development of cutting-edge technologies that have had a lasting impact on society.

Conclusion: Laurent Poirot's dedication to pushing the boundaries of what is possible and his unwavering commitment to creating a better future through innovation make him a true pioneer in the world of inventors. His legacy will continue to inspire generations to come.

Profile summary based on public USPTO records.